Areas of Research
- Tumor Heterogeneity
The Futreal Laboratory aims to describe the genomic underpinnings of cancer. We seek to discover the basis for new therapy development by finding genetic mutations that explain sensitivity or resistance to therapies.
Research in the Futreal Lab focuses on assessing tumor heterogeneity by multi-region sampling and tumor evolution by collecting longitudinal samples for all types of therapeutic treatments and analyzing these samples. We collaborate with clinicians and scientists throughout MD Anderson and abroad to determine how genomic information about our patients can be used to influence clinical care by developing better diagnostic tools and aiding in treatment-decision-making processes.
Collectively, our efforts are focused on developing personalized treatments for patients with cancer.
Meet the Team
Futreal Lab, 2019 (left to right): Jennifer Goldstein, Akash Mitra, Marcus Coyle, Kadir Akdemir, Curtis Gumbs, Sabitha Prabhakaran, Andy Futreal, Josh Baguley, Hannah Beird, Olivia Lee, Rebecca Thornton, Christigale Mandapat, Latasha Little